首頁 > 市場調查報告書 > 製藥

臨床實驗

市場調查報告書

商品編碼

1449590

全球口咽念珠菌念珠菌症市場：按類型、按治療、按給藥途徑、按分銷管道、按地區

Global Oropharyngeal Candidiasis Market, By Type, By Treatment, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年02月07日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球口咽念珠菌症市場價值為 4.56 億美元，預計到 2031 年將達到 6.304 億美元，2024 年至 2031 年年複合成長率為 4.1%。

報告範圍		報告詳情
基準年	2023年	2023/2024年市場規模	4.56 億美元
實際資料	2019-2023	預測期	2024-2031
預測期2023/2024~2030/2031年複合成長率：	4.10%	2030/2031 年預測值	6.304 億美元

圖 1. 2024 年口咽念珠菌念珠菌症全球市場佔有率(%)（按地區）

口咽念珠菌症（OPC），通常也稱為鵝口瘡，是由口腔和咽黏膜念珠菌（主要是白色念珠菌）過度生長引起的真菌感染疾病。念珠菌是口腔微生物群的正常組成部分，但在某些條件下，微生物的微妙平衡被破壞，念珠菌過度生長。常見於免疫系統較弱的族群，例如患有人類免疫力缺乏病毒/後天免疫力缺乏症候群（愛滋病毒/愛滋病）的人、接受化療的人以及服用廣譜抗生素的人。它也可能發生在糖尿病患者、服用皮質類固醇的患者和佩戴假牙的患者。這種感染疾病的特徵通常是舌頭、臉頰內側、上顎、牙齦、扁桃體和喉嚨後部出現白斑。這些病變可能會稍微隆起，在嚴重的情況下，可能會導致不適和吞嚥困難。念珠菌症是一種由於其在免疫力缺乏人群中的流行而在醫學研究和患者照護中受到高度關注的疾病。儘管念珠菌是無害的，並且是大多數人口腔菌群的標準居民，但多種情況都可能導致這種感染，包括免疫力缺乏、長期使用抗生素、糖尿病和某些藥物治療。機會性真菌感染疾病。這種感染疾病的特徵性症狀是口腔和咽部黏膜表面出現乳白色病變。這些病變有時會令人不舒服，如果廣泛傳播，可能會干擾適當的營養和吞嚥。 OPC 的治療通常涉及抗真菌藥物，重點是解決可能導致真菌過度生長的潛在疾病。市場分析表明，該疾病的治療領域受到全球糖尿病和愛滋病毒/愛滋病高盛行率的顯著影響，導致對有效抗真菌療法的需求不斷增加。

市場動態：

全球口咽念珠菌症市場是由愛滋病毒/愛滋病盛行率上升以及更容易受到真菌感染疾病的老年人口增加所推動的。此外，日益激進的腫瘤定向治療，以及頻譜抗生素和皮質類固醇治療的頻繁使用，正在加劇鵝口瘡的風險。然而，市場可能面臨限制因素，例如學名藥競爭加劇和替代治療方案的可用性。

本研究的主要特點

本報告對全球口咽念珠菌念珠菌症市場進行了詳細分析，並列出了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率。
它還說明了各個細分市場的潛在商機，並為該市場提供了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球口咽念珠菌念珠菌症市場的主要企業。
該報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球口咽念珠菌念珠菌症市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球口咽念珠菌念珠菌症市場的各種策略矩陣，將促進相關人員的決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
北非
中部非洲

第10章競爭格局

公司簡介
- Bayer AG
- Teva Pharmaceuticals
- Stellar Pharma
- Pfizer
- Wockhardt
- Ranbaxy Laboratories
- Bristol Laboratories
- Glenmark Pharmaceutical Ltd
- GlaxoSmithKline

第11章章節

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI6617

Global oropharyngeal candidiasis market was valued at US$ 456 Mn in 2023 and is expected to reach US$ 630.4 Mn by 2031, exhibiting at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 456 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	4.10%	2030/2031 Value Projection:	US$ 630.4 Mn

Figure 1. Global Oropharyngeal Candidiasis Market Share (%), By Region, 2024

Global Oropharyngeal Candidiasis Market - IMG1

Oropharyngeal candidiasis (OPC) which is also commonly known as oral thrush, is a fungal infection which is caused by the overgrowth of Candida species, predominantly Candida albicans, in the oral and pharyngeal mucous membranes. While Candida is a normal component of the oral microbiota, certain conditions can disrupt the delicate balance of microorganisms, thereby leading to its excessive proliferation. It is frequently observed in individuals with compromised immune systems, such as those with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), undergoing chemotherapy, or taking broad-spectrum antibiotics. It can also occur in patients with diabetes or those who use corticosteroids or wear dentures. The infection is typically characterized by white patches on the tongue, inner cheeks, and roof of the mouth, gums, tonsils, or the back of the throat. These lesions can be slightly raised and may cause discomfort or difficulty in swallowing when severe. It is a condition that has garnered significant attention within medical research and patient care due to its pervasive nature in immunocompromised populations. While Candida is a standard tenant of the oral flora among many individuals without causing harm, various circumstances, such as immunodeficiency, extended antibiotic use, diabetes, and certain medical therapies, can predispose individuals to this opportunistic fungal infection. The hallmark symptoms of this infection consist of creamy white lesions that appear on the mucosal surfaces of the oral cavity and the throat. These lesions are sometimes accompanied by discomfort and can impede proper nutrition and swallowing when they are extensive. The treatment landscape for OPC typically involves antifungal medications, with an emphasis on addressing any underlying conditions that may have led to the fungal overgrowth. Market analysis reveals that the therapeutic area for this condition is significantly influenced by the high prevalence of diabetes and HIV/AIDS globally, with a resultant increase in demand for efficacious antifungal therapies.

Market Dynamics:

Global oropharyngeal candidiasis market is driven by the rising prevalence of HIV/AIDS along with a growing elderly population that is susceptible to fungal infections. Moreover, increasingly aggressive tumor-directed therapies along with frequent use of broad-spectrum antibiotic and corticosteroid therapies spur the risk of oral thrush. However, the market potentially faces restraints from rising generics competition and availability of alternate treatment options.

Key features of the study:

This report provides in-depth analysis of the global oropharyngeal candidiasis market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global oropharyngeal candidiasis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Bayer AG, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Ranbaxy Laboratories, Bristol Laboratories, Glenmark Pharmaceuticals Ltd, and GlaxoSmithKline.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global oropharyngeal candidiasis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oropharyngeal candidiasis market.

Detailed Segmentation:

Global Oropharyngeal Candidiasis Market, By Type
- Pseudomembranous
- Erythematous
- Hyperplastic
Global Oropharyngeal Candidiasis Market, By Treatment
- Anti-fungal
- Immune-modulators
Global Oropharyngeal Candidiasis Market, By Route of Administration
- Oral
- Topical
- Others
Global Oropharyngeal Candidiasis Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Oropharyngeal Candidiasis Market, By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Top Companies in Global Oropharyngeal Candidiasis Market:
- Bayer AG
- Teva Pharmaceuticals
- Stellar Pharma
- Pfizer
- Wockhardt
- Ranbaxy Laboratories
- Bristol Laboratories
- Glenmark Pharmaceuticals Ltd
- GlaxoSmithKline

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Oropharyngeal Candidiasis, By Type
- Market Oropharyngeal Candidiasis, By Treatment
- Market Oropharyngeal Candidiasis, By Route of Administration
- Market Oropharyngeal Candidiasis, By Distribution Channel
- Market Oropharyngeal Candidiasis, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
Increasing prevalence of HIV/AIDS
Rising research funding and projects
Increasing number of healthcare facilities
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Oropharyngeal Candidiasis Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Oropharyngeal Candidiasis Market, By Type, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Pseudomembranous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Erythematous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Hyperplastic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Oropharyngeal Candidiasis Market, By Treatment, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020-2031
- Segment Trends
Anti-fungal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Immune-modulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Oropharyngeal Candidiasis Market, By Route of Administration, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020-2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Oropharyngeal Candidiasis Market, By Distribution Channel, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020-2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

9. Global Oropharyngeal Candidiasis Market, By Region, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2031
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031 ,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031, (US$ Mn)
South Africa
North Africa
Central Africa